Yes. I think that we have reached a certain plateau currently with regard to molecules that can attenuate symptoms at the dementia stage. However, we may be luckier with new models or new molecules. Also, as the lady was saying, we may develop an original approach that may derive from observation in the context of another disease, which could apply to many other cerebral pathologies.
We need to invest in prevention at this time. We have a whole cohort of baby boomers, and I am one of them, who are aware of the risks and who may be willing to invest some of their own funds. To add something to the reply given to Ms. Duncan earlier, I would say that if we could get the public fired up about the prevention of neurological diseases, we might be able to obtain private investment to add to the funds available from the federal level.